Lilly (LLY: news, chart, profile) said it was adding the warning after an analysis requested by the Food and Drug Administration of previous clinical data showed 0.4% of the children who took the drug experienced suicidal thoughts. The analysis also showed that no such thinking was reported amongst children who took a placebo.
No comments:
Post a Comment